PhD, FRSE
Emeritus Professor
- About
-
- Email Address
- n.a.booth@abdn.ac.uk
- Office Address
Institute of Medical Sciences University of Aberdeen Aberdeen AB25 2ZD UK
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
Membership of Learned Societies:
- International Society on Thrombosis and Haemostasis (Elected to Council, 2008-2014, Chairman Finance Committee 2009 to 2014),; formerly Chairman of Scientific Standardization Committee (2006-2008), chairman of the Subcommittee on Fibrinolysis (1997-2000) and Hon Secretary of the Council on Thrombosis (1998-2002)
- International Society for Fibrinolysis and Proteolysis (on Council 1996-2005; Chairman 2002-2004)
- British Society for Thrombosis and Haemostasis (President 1997; Treasurer 1991-96)
- International Fibrinogen Research Society
- The Biochemical Society
- British Atherosclerosis Society
- Scottish Cardiovascular Forum
- Research
-
Research Overview
Our research is directed at a better understanding of fibrin and its stabilization, which is relevant to thrombosis and atherosclerosis. We focus on the plasmin system, which is central to the degradation of blood clots and extracellular matrix and to the activation of growth factors. Our studies include characterization of the major proteins of this pathway, the plasminogen activators, tPA and uPA, and the inhibitors, PAI-1, PAI-2 and að2-antiplasmin. Our work includes structure-function relationships in these proteins, their cellular roles and their importance in thrombus lysis and in the protection of the vessel wall from atherosclerosis. Localization of these and related proteins by transglutaminases is a particular interest. We also have a broad interest in microbial proteases in relation to pathogenic mechanisms.
- Publications
-
Page 4 of 5 Results 31 to 40 of 44
TAFI meets the sticky ends
Thrombosis and Haemostasis, vol. 85, no. 1, pp. 1-2Contributions to Journals: ArticlesAn ELISA for the detection of Bacillus subtilis L-form bacteria confirms their symbiosis in strawberry
Letters in Applied Microbiology, vol. 31, pp. 390-394Contributions to Journals: ArticlesCross-linking of plasminogen activator inhibitor 2 and alpha(2)-antiplasmin to fibrin(ogen)
The Journal of Biological Chemistry, vol. 275, pp. 24915-24920Contributions to Journals: ArticlesEffective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha(2)-antiplasmin
British Journal of Haematology, vol. 111, pp. 517-523Contributions to Journals: ArticlesMyeloid leukaemic cells can lyse fibrin directly
British Journal of Haematology, vol. 111, pp. 524-529Contributions to Journals: ArticlesPlasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis
British Journal of Haematology, vol. 109, pp. 342-348Contributions to Journals: ArticlesRegulation of fibrinolytic activity by localization of inhibitors to fibrin(ogen)
Fibrinolysis and Proteolysis, vol. 14, pp. 206-213Contributions to Journals: ArticlesRegulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells
British Journal of Ophthalmology, vol. 84, pp. 417-422Contributions to Journals: ArticlesCirculating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: a pilot study
Acta Diabetologica, vol. 36, pp. 155-158Contributions to Journals: ArticlesFibrinolysis and thrombosis
Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 12, pp. 423-433Contributions to Journals: Articles